Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Lene Ryom(University of Copenhagen), Andrew Phillips(Wake Forest University), Wafaa El‐Sadr(Columbia University Irving Medical Center), Ole Kirk(University of Copenhagen), Éric Fontas(Université Côte d'Azur), Amanda Mocroft(University of Copenhagen), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caroline Sabin(Primary Health Care), Christoph Andreas Fux(University of Bern), Camilla I. Hatleberg, Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre), Mike Ross(Albert Einstein College of Medicine), Phillip Morlat(Université de Bordeaux), Peter Reiß(University of Amsterdam)
Cited by 20
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k